Researchers have not identified a lethal dose even at concentrations far exceeding therapeutic ranges
Sikiric P, Seiwerth S, Mise S, et al
The compound demonstrates blood-brain barrier (BBB) penetration efficiency approximately 1000-fold higher than comparable peptidesa critical factor in determining how frequently administration is required to maintain central nervous system concentrations adequate for receptor engagement
BPC-157 Nasal Spray Specifications Sizes and Concentration: BPC-157 15ml: Contains 2mg of BPC-157, designed for preliminary research phases or smaller-scale studies
Undesirable symptoms of drug addiction include increased tolerance to intoxicating substances, continuing drug use despite unpleasant health, mental, and social consequences, and the appearance of withdrawal syndrome such as hand and muscle tremors, excessive sweating, irritability, hallucinations, depression, concentration deterioration, and anxiety